Skip to main content

PAVmed Inc.

PAVM
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001624326

No open-market purchases or sales by PAVmed Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $5.56M in total; no superinvestor holds it.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, 0 vs. previous quarter
19
13F valueReported value at the end of Q2 2026
$5.56M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding PAVM, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding PAVM at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by PAVmed Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 7, 2022 (view filing)Dec 52 daysGlennon Michael JDirectorPPurchase+62.0K$0.69+$42.8KNew position62.0K after
Dec 7, 2022 (view filing)Dec 6-71 dayGlennon Michael JDirectorPPurchase+188.0K$0.6294+$118.3K+303.2%250.0K after2 lots

Top 10 13F holders, Q2 2026

The largest institutional positions in PAVmed Inc. at the end of Q2 2026; share changes are against Q1 2026.

See all 19 holders
Institutions holding PAVM in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Two Seas Capital LP461,539$2.74M0.10%00.0%Unchanged
First Manhattan Co332,911$1.98M0.01%+309,106+1,298.5%Added
Vanguard Capital Management LLC61,604$365.9K0.00%+55,687+941.1%Added
Geode Capital Management, LLC36,678$217.9K0.00%+24,901+211.4%Added
Vanguard Fiduciary Trust Co25,605$152.1K0.00%+20,176+371.6%Added
BlackRock, Inc.17,092$101.5K0.00%+14,676+607.5%Added
Morgan Stanley163$9680.00%−2−1.2%Reduced
Barclays PLC75$4460.00%+75New
SBI Securities Co., Ltd.67$3980.00%00.0%Unchanged
UBS Group AG57$3390.00%−18−24.0%Reduced